Movement Alert｜10x Genomics, Inc. Falls 5.26% in After-Hours Trading, Q2 Revenue Drops 12.7% YoY with Swing to Loss

Market Focus08-07 04:31

On August 7, 10x Genomics, Inc. fell 5.26% in after-hours trading, trading at $43.0 per share, with turnover of $4.47 million.

On the news front, the company reported Q2 results showing a per-share loss of $0.14, which beat the analyst consensus estimate of a $0.24 loss. Revenue of $151.0 million also exceeded the $146.8 million estimate. However, revenue declined 12.7% year-over-year from $172.9 million, and the company swung from earnings of $0.28 per share a year earlier to a loss, signaling fundamental deterioration that triggered selling pressure despite the headline beats.

The company raised its full-year revenue guidance to $610 million-$630 million, up from prior guidance of $600 million-$625 million, compared with the analyst consensus of $613.7 million. Nevertheless, the sharp year-over-year revenue contraction and the profit-to-loss reversal weighed on investor sentiment. Earlier in the regular session, the stock had already declined approximately 5% amid broader weakness in the life sciences tools sector.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1103086687?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-07 04:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1103086687","market":"us","top_or_hot":-1,"title":"Movement Alert｜10x Genomics, Inc. Falls 5.26% in After-Hours Trading, Q2 Revenue Drops 12.7% YoY with Swing to Loss","media":"Market Focus","content":"<p><p>On August 7, 10x Genomics, Inc. fell 5.26% in after-hours trading, trading at $43.0 per share, with turnover of $4.47 million.</p><p>On the news front, the company reported Q2 results showing a per-share loss of $0.14, which beat the analyst consensus estimate of a $0.24 loss. Revenue of $151.0 million also exceeded the $146.8 million estimate. However, revenue declined 12.7% year-over-year from $172.9 million, and the company swung from earnings of $0.28 per share a year earlier to a loss, signaling fundamental deterioration that triggered selling pressure despite the headline beats.</p><p>The company raised its full-year revenue guidance to $610 million-$630 million, up from prior guidance of $600 million-$625 million, compared with the analyst consensus of $613.7 million. Nevertheless, the sharp year-over-year revenue contraction and the profit-to-loss reversal weighed on investor sentiment. Earlier in the regular session, the stock had already declined approximately 5% amid broader weakness in the life sciences tools sector.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜10x Genomics, Inc. Falls 5.26% in After-Hours Trading, Q2 Revenue Drops 12.7% YoY with Swing to Loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜10x Genomics, Inc. Falls 5.26% in After-Hours Trading, Q2 Revenue Drops 12.7% YoY with Swing to Loss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-07 04:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 7, 10x Genomics, Inc. fell 5.26% in after-hours trading, trading at $43.0 per share, with turnover of $4.47 million.</p><p>On the news front, the company reported Q2 results showing a per-share loss of $0.14, which beat the analyst consensus estimate of a $0.24 loss. Revenue of $151.0 million also exceeded the $146.8 million estimate. However, revenue declined 12.7% year-over-year from $172.9 million, and the company swung from earnings of $0.28 per share a year earlier to a loss, signaling fundamental deterioration that triggered selling pressure despite the headline beats.</p><p>The company raised its full-year revenue guidance to $610 million-$630 million, up from prior guidance of $600 million-$625 million, compared with the analyst consensus of $613.7 million. Nevertheless, the sharp year-over-year revenue contraction and the profit-to-loss reversal weighed on investor sentiment. Earlier in the regular session, the stock had already declined approximately 5% amid broader weakness in the life sciences tools sector.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TXG","symbol_name":"10x Genomics, Inc.","start_time":0,"source_url":"","article_id":"1103086687","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1103086687","pubTimestamp":1786048317,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 7, 10x Genomics, Inc. fell 5.26% in after-hours trading, trading at $43.0 per share, with turnover of $4.47 million.On the news front, the company reported Q2 results showing a per-share...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TXG":"10x Genomics, Inc."},"translate_title":"走势警报|10x Genomics, Inc. 盘后交易中下跌 5.26%，第二季度收入同比下降 12.7%，转为亏损","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TXG":1},"content_text":"On August 7, 10x Genomics, Inc. fell 5.26% in after-hours trading, trading at $43.0 per share, with turnover of $4.47 million.On the news front, the company reported Q2 results showing a per-share loss of $0.14, which beat the analyst consensus estimate of a $0.24 loss. Revenue of $151.0 million also exceeded the $146.8 million estimate. However, revenue declined 12.7% year-over-year from $172.9 million, and the company swung from earnings of $0.28 per share a year earlier to a loss, signaling fundamental deterioration that triggered selling pressure despite the headline beats.The company raised its full-year revenue guidance to $610 million-$630 million, up from prior guidance of $600 million-$625 million, compared with the analyst consensus of $613.7 million. Nevertheless, the sharp year-over-year revenue contraction and the profit-to-loss reversal weighed on investor sentiment. Earlier in the regular session, the stock had already declined approximately 5% amid broader weakness in the life sciences tools sector.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1103086687","isCrawlerRequest":true}